KOL Event

Inspire Medical – KOL Event and Platform Drive Visibility Prior to IPO

October 12, 2021

Inspire Medical became a LifeSci Advisors client pre-IPO. The teams collaborated to develop and execute a robust, best-in-class investor relations program to engage the investment community The Process A successful strategically timed KOL event before going live on the IPO was well attended by investors and sell-side analysts, attracting potential investors new to the story…

Read More

KOL Event DarioHealth (DRIO)

October 12, 2021

Using our interactive virtual platform, LifeSci hosted a total of 96 overall attendees, both via webcast and over the phone, including institutional investors, sell-side analysts, bankers, high net worth investors, and strategics.  

Read More

LifeSci hosts Analyst Day for MediWound

October 12, 2021

With our proprietary distribution network, LifeSci hosted a total of 108 overall attendees, including institutional investors, sell-side analysts, bankers, high net worth investors, and strategics   What: Analyst Day: EscharEx® When: January 28, 2021 Who: Robert S. Kirsner, M.D., Ph.D., (University of Miami) Adam J. Singer, M.D. (Stony Brook University) Robert J. Snyder, D.P.M., M.Sc.…

Read More

BioInvent KOL Call on Relapsed or Refractory Non-Hodgkin’s Lymphoma – $116M Raise

October 12, 2021

With our proprietary distribution network, LifeSci hosted a total of 140 overall attendees, including institutional investors, sell-side analysts, bankers, high net worth investors, and strategics   What: KOL Call on BI-1206 for Relapsed or Refractory Non-Hodgkin’s Lymphoma When: January 28, 2021 Who: Dr. Martin Welschof, CEO Dr. Andres McAllister, CMO Dr. Björn Frendéus, CSO Dr.…

Read More